Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma‐product exposed toddlers)

The epidemiology of inhibitors in haemophilia A: a systematic review

2003 • 603 citations

Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors

1993 • 482 citations

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study

2007 • 477 citations

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

2003 • 367 citations

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A

2005 • 300 citations

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

2006 • 187 citations

Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age

2001 • 178 citations

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII

1993 • 164 citations

Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A

2005 • 98 citations

Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand Factor

1996 • 96 citations

French Previously Untreated Patients with Severe Hemophilia A after Exposure to Recombinant Factor VIII : Incidence of Inhibitor and Evaluation of Immune Tolerance

1998 • 90 citations

Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients

2001 • 65 citations

Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations

1996 • 63 citations

Incidence of Factor VIII Inhibitor Development in Severe Hemophilia A Patients Treated only with One Brand of Highly Purified Plasma-Derived Concentrate

1995 • 44 citations